CASM - CAS Medical Systems, Inc.

CAS Medical Systems, Inc. (CASM) is a publicly-traded medical technology company that focuses on the development and commercialization of non-invasive monitoring solutions for patient care. The company was founded in 1984 and is headquartered in Branford, Connecticut.

CASM's primary product is the FORE-SIGHT Absolute Tissue Oximeter, which is used in hospitals and medical facilities to monitor the oxygen saturation of patients' brains during surgery. The company also provides a range of sensors and accessories that are compatible with the FORE-SIGHT system.

As of early 2021, the market capitalization of CASM was approximately $15 million. The company has a strong reputation in the industry and has received various awards for its technology and innovation.

Investing in medical technology companies like CASM carries certain risks, including the potential for market fluctuations, regulatory risks, and clinical trial risks. Additionally, the success of a company's products is dependent on several factors, including the safety and efficacy of the products and the ability to obtain regulatory approval. Potential investors should carefully consider these risks before making any investment decisions.